O-Xylene

O-Xylene

SCHEMBL5353236

COCCOCCOCCOCCOC.Cc1ccccc1C

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.50
ACHE P22303 1/20 0.50
CA2 P00918 1/20 0.41
MEN1 O00255 2/20 0.39
LMNA P02545 2/20 0.39
KMT2A Q03164 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.37
ALDH1A1 P00352 6/20 0.36
KDM4E B2RXH2 3/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C19 P33261 2/20 0.36
ALOX15 P16050 1/20 0.36
HIF1A Q16665 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MAPT P10636 1/20 0.36
TP53 P04637 1/20 0.36
USP2 O75604 1/20 0.36
APEX1 P27695 1/20 0.36
CASP7 P55210 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
O-Xylene SCHEMBL9375721 1.00 TSHR (0.50) TSHRACHECA2MEN1LMNA
O-Xylene SCHEMBL828121 0.92 TSHR (0.59) TSHRACHECA2MEN1KMT2A
Orthocresol SCHEMBL27258627 0.85 TSHR (0.40) TSHRACHECA2MEN1LMNA
SCHEMBL27516004 0.83 TAAR1 (0.48) TSHRCA2ALDH1A1KDM4E
SCHEMBL21169162 0.83 ALDH1A1 (0.50) TSHRLMNAKMT2AL3MBTL1ALDH1A1
Toluene SCHEMBL11563168 0.83 TSHR (0.52) TSHRACHECA2MEN1LMNA
Toluene SCHEMBL8205760 0.83 TSHR (0.52) TSHRACHECA2MEN1LMNA
SCHEMBL17668299 0.81 ALDH1A1 (0.57) TSHRMEN1LMNAKMT2AL3MBTL1
Biphenyl SCHEMBL28018683 0.80 CA2 (0.45) TSHRCA2MEN1LMNAKMT2A
O-Xylene SCHEMBL16163023 0.78 TSHR (0.48) TSHRACHECA2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8871878-B2 Ethylene polymerization using discrete nickel(II) iminophosphonamide complexes THE UNIVERSITY OF AKRON (US) 2014-10-28 US disclosed
US-20130123444-A1 ETHYLENE POLYMERIZATION USING DISCRETE NICKEL(II) IMINOPHOSPHONAMIDE COMPLEXES THE UNIVERSITY OF AKRON (US) 2013-05-16 US disclosed
WO-2007109232-A2 ETHYLENE POLYMERIZATION USING DISCRETE NICKEL (II) IMINOPHOSPHONAMIDE COMPLEXES UNIVERSITY OF AKRON (US) 2007-09-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130123444-A1 ETHYLENE POLYMERIZATION USING DISCRETE NICKEL(II) IMINOPHOSPHONAMIDE COMPLEXES NIT2, MAL2, MCM2 TSHR 4725/4885ACHE 1790/4885CA2 460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.